Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

United Therapeutics (UTHR) Return on Equity (2016 - 2025)

United Therapeutics (UTHR) has disclosed Return on Equity for 16 consecutive years, with 0.2% as the latest value for Q4 2025.

  • Quarterly Return on Equity changed 0.0% to 0.2% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.2% through Dec 2025, changed 0.0% year-over-year, with the annual reading at 0.2% for FY2025, 0.0% changed from the prior year.
  • Return on Equity hit 0.2% in Q4 2025 for United Therapeutics, up from 0.18% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 0.2% in Q4 2025 to a low of 0.12% in Q1 2021.
  • Historically, Return on Equity has averaged 0.16% across 5 years, with a median of 0.17% in 2023.
  • Biggest five-year swings in Return on Equity: fell -7bps in 2021 and later rose 5bps in 2022.
  • Year by year, Return on Equity stood at 0.12% in 2021, then grew by 27bps to 0.16% in 2022, then grew by 8bps to 0.17% in 2023, then rose by 13bps to 0.19% in 2024, then grew by 2bps to 0.2% in 2025.
  • Business Quant data shows Return on Equity for UTHR at 0.2% in Q4 2025, 0.18% in Q3 2025, and 0.18% in Q2 2025.